Back

Mitral valve prolapse: arrhythmic risk and prognosis

19 May 2025 (11:00 - 11:45)
Organised by: Logo
Congress Presentation Part of: Valve disease and heart failure - recognising opportunities Clinical HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Monica Dias

Hospital de Braga, Braga (Portugal)

3 More presentations in this session

Presentation thumbnail
Catheter ablation in atrial fibrillation with concomitant mitral regurgitation: insights from the CABANA trial
Doctor S. Dhont (Genk, BE)
Abstract Slides Video
Presentation thumbnail
Right ventricular-arterial coupling measured by cardiac magnetic resonance associates with outcomes: insights from a large cohort of patients with tricuspid regurgitation
Doctor D. Margonato (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Development of tricuspid regurgitation after left-side heart surgery
Doctor M. Dias (Braga, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Valve disease and heart failure - recognising opportunities

The Event

Event poster

Heart Failure 2025

19 May 2025 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Arrhythmic MVP: identifying and protecting vulnerable patients
13 April 2026
thumbnail
Congress Presentation
Prevalence and cardiovascular implications of mitral valve prolapse in marfan syndrome: insights from a multicenter observational study
30 August 2025
thumbnail
Congress Presentation
Risk of arrhythmias in women with mitral valve prolapse during pregnancy and puerperium
31 August 2025
thumbnail
Congress Presentation
Progressive electrical and structural remodelling in mitral valve prolapse: implications for arrhythmic risk stratification
12 April 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources